AutoICD API

79719-1

Laboratory

DPYD gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method

Definition

The DPYD gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting DPYD gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html]

LOINC 6-Axis Classification

Component

DPYD gene product metabolic activity interpretation

Property

Imp

Time Aspect

Pt

System

Bld/Tiss

Scale Type

Ord

Method Type

Molgen

Details

Class

MOLPATH.PHARMG

Order/Observation

Observation

Short Name

DPYD gene prod met act imp Bld/T-Imp

Display Name

DPYD gene product metabolic activity interpretation Molgen Ql (Bld/Tiss) [Interp]

Related Names

ActivActvtyBloodDHPDHPDHASEdihydropyrimidine dehydrogenaseDihydropyrimidine dehydrogenase geneDihydrothymine dehydrogenase geneDihydrouracil dehydrogenase geneDPDDPYD gene prod met act impDrug metabolismGene prod met act impImpressionImpression/interpretation of studyImpressionsInterpInterpretInterpretationInterptIntrpMolecular geneticsMolecular pathologyMOLPATHMOLPATH.PHARMGMovementsOrdinalPCRPhenotypePoint in timeQLQualQualitativeRandomScreenTissueTissue, unspecifiedWBWhole bloodWhole blood or Tissue

Frequently Asked Questions

What is LOINC code 79719-1?

LOINC code 79719-1 identifies "DPYD gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method". The DPYD gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting DPYD gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html]

What does 79719-1 measure?

This code measures DPYD gene product metabolic activity interpretation in Bld/Tiss. It belongs to the MOLPATH.PHARMG class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.